XML 34 R19.htm IDEA: XBRL DOCUMENT v3.22.1
Long-Term Debt, Net, and Other Borrowings
 3 Months Ended
Mar. 31, 2022
Debt Disclosure [Abstract]  
Long-Term Debt, Net, and Other Borrowings Long-Term Debt, Net, and Other Borrowings
As of March 31, 2022, the Company’s maturities of principal obligations under its long-term debt and other borrowings are as follows:
(in thousands)Amount
Remainder of 2022$8,750 
202315,000 
2024148,750 
Total principal outstanding172,500 
Unamortized debt discount(448)
Unamortized debt issuance costs(387)
Finance lease liabilities582 
Total172,247 
Less: current portion(12,878)
Total long-term debt, net and other borrowings$159,369 


At March 31, 2022, the Company’s interest rate under the five-year secured term loan facility, which matures on June 30, 2024 (the “2019 Term Facility” and the loans thereunder, the “2019 Term Loans”) was 2.2%.
On March 31, 2021, the Company voluntarily repaid in full the entire outstanding principal on the original $50.0 million loan agreement (the “Royalty-Backed Loan”) with a fund managed by HealthCare Royalty Partners III, L.P. in the amount of $30.9 million, which included a prepayment amount of $0.5 million, and terminated the agreement governing the Royalty-Backed Loan. The Company recorded a gain on extinguishment of debt of $0.9 million related to the write-off of an unamortized debt premium offset by the prepayment amount.